10x Genomics, Inc. TXG Spatial — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s spatial — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s spatial — revenue?
- 10x Genomics, Inc. (TXG) reported spatial — revenue of $6.04M in Q1 2026.
- How has 10x Genomics, Inc.'s spatial — revenue changed year-over-year?
- 10x Genomics, Inc.'s spatial — revenue decreased by 32.2% year-over-year, from $8.9M to $6.04M.
- What is the long-term trend for 10x Genomics, Inc.'s spatial — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s spatial — revenue has grown at a 225.7% compound annual growth rate (CAGR), from $303K to $34.11M.
- What does spatial — revenue mean?
- This metric represents the total revenue generated specifically from the sale of instruments within the spatial biology product segment. It serves as a key indicator of market adoption for the company's hardware platforms and reflects the initial capital investment made by research institutions and laboratories. Growth in this area typically signals a expanding installed base that will drive future demand for recurring consumable products.